Differential expression of the angiogenesis growth factors in psoriasis vulgaris

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Liew, Siaw Cheok ^a   Das Gupta, Esha ^a   Chakravarthi, Srikumar ^a   Wong, Shew Fung ^a   Lee, Nagarajah ^b   Safdar, Najeeb ^c   Jamil, Adawiyah ^d  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b Open University   (Malaysia)

^c Hospital Tuanku Jaafar   (Malaysia)

^d HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PSORIASIS; SKIN; VASCULARIZATION;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTOR; PREGNANCY PROTEINS; PSORIASIS; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 84862157439     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-201     Document Type: Article

References (69)

1. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Folkman J, Nat Med 1995 1 27 31 10.1038/nm0195-27 7584949
2. Angiogenesis in psoriasis: Therapeutic implications. Folkman J, J Invest Dermatol 1972 59 40 43 10.1111/1523-1747.ep12625746 5039962
3. Angiogenesis in psoriasis. Creamer D, Sullivan D, Bicknell R, Barker J, Angiogenesis 2002 5 231 236 10.1023/A:1024515517623 12906316 (Pubitemid 36875122)
4. Localisation of endothelial proliferation and microvascular expansion in active plaque psoriasis. Creamer D, Allen M, Sousa A, Poston R, Barker J, Br J Dermatol 1997 136 859 865 10.1111/j.1365-2133.1997.tb03925.x 9217817 (Pubitemid 27283516)
5. The primary histologic lesion of seborrhoeic dermatitis and psoriasis. Pinkus H, Mehregan A, J Invest Dermatol 1966 46 109 116 4222023
6. Investigations of the active edge of plaque psoriasis: Vascular proliferation precedes changes in epidermal keratin. Goodfield M, Macdonald Hull S, Holland D, Roberts G, Wood E, Reid S, Cunlife W, Br J Dermatol 1994 131 808 813 10.1111/j.1365-2133.1994.tb08582.x 7532001 (Pubitemid 24373958)
7. Role of the microcirculation in the treatment and pathogenesis of psoriasis. Braverman I, Sibley B, J Invest Dermatol 1982 78 12 17 10.1111/1523-1747.ep12497850 7054305 (Pubitemid 12207148)
8. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. Braverman M, Yen A, J Invest Dermatol 1977 68 53 60 10.1111/1523-1747.ep12485169 830771 (Pubitemid 8019017)
9. The human gene for vascular endothelial growth factor. Tisher E, Mitchell R, Hartmann T, Silva M, Gospodarowicz D, Fiddes J, Abraham J, J Biol Chem 1991 266 11947 11954 1711045
10. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. deVaries C, Escobedo J, Ueno H, Houck K, Ferrara N, Williams L, Science 1992 255 989 991 10.1126/science.1312256 1312256
11. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Terman B, Vermazen M, Carrion M, Dimitrov D, Armellino D, Gospodarowicz D, Bohlen P, Biochem Biophys Res Commun 1992 34 1578 1586
12. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Shibuya M, Yamaguchi S, Yamane A, Tojo T, Matsushime M, Oncogene 1990 8 519 527
13. Identification of a new endothelial growth factor receptor tyrosine kinase. Terman B, Carrion M, Kovacs E, Rasmussen B, Eddy R, Shows T, Oncogene 1991 6 519 524
14. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Matthews W, Jordan C, Gavin MN, Copeland N, Lemischka I, Proc Natl Acad Sci Unit States Am 1991 88 9026 9030 10.1073/pnas.88.20.9026 (Pubitemid 21915561)
15. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW, Mol Endocrinol 1991 5 1806 1814 10.1210/mend-5-12-1806 1791831
16. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Eriksson U, Alitalo K, Curr Top Microbiol Immunol 1999 237 41 57 10.1007/978-3-642-59953-8-3 9893345 (Pubitemid 28554858)
17. The biology of VEGF and its receptor. Ferrara N, Gerber H, LeCouter J, Nat Med 2003 9 669 676 10.1038/nm0603-669 12778165 (Pubitemid 36749215)
18. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Bhushsn M, McLaughin B, Weiss C, Griffiths C, Br J Dermatol 1999 141 1054 1060 10.1046/j.1365-2133.1999. 03205.x 10606852 (Pubitemid 30046195)
19. Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis - A possible target for novel therapies? Canavese M, Altruda F, Ruzicka T, et al. J Dermatol Sci 2010 58 171 176 10.1016/j.jdermsci.2010.03.023 20430590
20. The biology of vascular endothelial growth factor. Ferrara N, Davis-Smyth T, Endocr Rev 1997 18 4 25 10.1210/er.18.1.4 9034784 (Pubitemid 27076453)
21. Abnormal blood vessel development and lethality in embryos lacking in a single VEGF allele. Carmeliet P, Nature 1996 280 435 439 (Pubitemid 26102719)
22. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Ferrara N, Nature 1996 380 439 442 10.1038/380439a0 8602242 (Pubitemid 26102720)
23. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Gerber H, Nat Med 1999 5 623 628 10.1038/9467 10371499 (Pubitemid 29289424)
24. Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaired wound healing. Frank S, Hubner G, Breier G, Longaker M, Greenhalgh D, Werner S, J Biol Chem 1995 270 12607 12613 10.1074/jbc.270.21. 12607 7759509
25. Over-expression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. Detmar M, Brown L, Claffey K, Yeo K, Kocher O, Jackman R, Berse B, Dvorak H, J Exp Med 1994 180 1141 1146 10.1084/jem.180.3.1141 8064230 (Pubitemid 24256627)
26. Keratinocytes derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. Detmar M, Yeo K, Nagy J, Van de Water L, Brown L, Berse B, Elicker S, Dvorak H, J Invest Dermatol 1995 105 44 50 10.1111/1523-1747.ep12312542 7615975
27. Vascular endothelial growth factor is expressed in rat corpus luteum. Phillips H, Hains J, Leung D, Ferrara N, Endocrinol 1990 127 965 967 10.1210/endo-127-2-965 (Pubitemid 20248145)
28. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin H, Lab Invest 1998 78 1385 1394 9840613 (Pubitemid 28546082)
29. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Ferrara N, Nat Med 1998 4 336 340 10.1038/nm0398-336 9500609 (Pubitemid 28144094)
30. Association of the vascular endothelial growth factor expression with intratumoural microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Mattern J, Koomagi R, Volm M, Br J Cancer 1996 73 931 934 10.1038/bjc.1996.166 8611409 (Pubitemid 26110166)
31. Up-regulation of vascular endothelial growth factor (VEGF) and down-regulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumours and cell lines. Vitlietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Persico M, Oncogene 1995 11 1569 1579 7478581
32. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Brown L, Berse B, Jackman R, Guidi A, Dvorak H, Senger D, Schnitt S, Hum Pathol 1995 26 86 91 10.1016/0046-8177(95) 90119-1 7821921
33. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Suzuki K, Hayashi N, Miyamoto M, Ohkawa K, Ito Y, Sasaki Y, et al. Cancer Res 1996 56 3004 3009 8674055 (Pubitemid 26199745)
34. Increased expression of vascular permeability factor/vascular endothelial growth factor in kidney and bladder carcinomas. Brown L, Berse B, Jackman R, Tognazzi K, Manseau E, Dvorak H, Senger D, Am J Pathol 1993 143 1255 1262 8238242 (Pubitemid 24057094)
35. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Olson T, Mohanraj D, Carson L, Ramakrishnan S, Cancer Res 1994 54 276 280 8261452 (Pubitemid 24042123)
36. Vascular permeability factor/vascular endothelial growth factor expression and angiogenesis in cervical neoplasia. Guidi A, Abu-Jahweh G, Berse B, Jackman R, Tognazzi K, Dvorak H, Brown L, J Natl Canc Inst 1995 87 12137 12145
37. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. Brown L, Yeo K, Berse B, Yeo T, Senger T, Dvorak H, van De Water L, J Exp Med 1992 176 1375 1379 10.1084/jem.176.5.1375 1402682
38. Immuno-localisation and expression of vascular endothelial growth factor receptors (VEGFRs) and neurophilins (NRPs) on keratinocytes in human epidermis. Man X, Yang X, Cai S, Yao Y, Zheng M, Mol Med 2006 12 127 136 17088944 (Pubitemid 44646341)
39. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Elias P, Arbiser J, Brown B, Rossiter H, Man Q, Cerimele F, Crumrine D, Gunathilake R, Choi E, Uchida Y, Tschachler E, Feingold K, Am J Pathol 2008 173 689 699 10.2353/ajpath.2008.080088 18688025
40. The role of VEGF and thrombospondins in skin angiogenesis. Detmar M, J Dermatol Sci 2000 24 78 S84 11137400
41. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. Detmar M, Brown L, Schon M, Elicker B, Velasco P, Richard L, Fukumura D, Monsky W, Claffey K, Jain R, J Invest Dermatol 1998 111 1 6 10.1046/j.1523-1747.1998.00262.x 9665379 (Pubitemid 28309201)
42. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Olofsson B, Pajusola K, Kaipaineen A, VonEuler G, Joukov V, Saksela O, Orpana A, Petterson R, Alitalo K, Eriksson U, Proc Natl Acad Sci Unit States Am 1996 93 2576 2581 10.1073/pnas.93.6.2576 (Pubitemid 26104389)
43. Cloning and characterization of a human gene related to vascular endothelial growth factor. Grimmond S, Lagencrantz J, Drinkwater C, Silins G, Townson S, Pollock P, Gotley D, Carson E, Rakar S, Nordenskjold M, Ward L, Hayward N, Weber G, Genome Res 1996 6 124 131 10.1101/gr.6.2.124 8919691 (Pubitemid 26111339)
44. A novel vascular endothelial growth factor, VEGF-C is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K, EMBO J 1996 15 290 298 8617204 (Pubitemid 26029207)
45. Vascular endothelial growth factor related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Lee J, Gray A, Yuan L, Luoh S, Avraham H, Wood W, Proc Natl Acad Sci Unit States Am 1996 93 1988 1992 10.1073/pnas.93.5.1988 (Pubitemid 26079868)
46. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Yamada Y, Nezu J, Miyuki S, Hirata Y, Genomics 1997 42 483 488 10.1006/geno.1997.4774 9205122 (Pubitemid 27287391)
47. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Stacker S, Caesar C, Baldwin M, Thornton G, Williams R, Prevo R, Jackson D, Nishikawa S, Kubo H, Achen M, Nat Med 2001 7 186 191 10.1038/84635 11175849 (Pubitemid 32148485)
48. Placenta growth factor is induced in human keratinocytes during wound healing. Failla C, Odorisio T, Cianfarani F, Schietroma C, Puddu P, Zambruno G, J Invest Dermatol 2000 115 387 395
49. The placenta growth factor in angiogenesis. Odorisio T, Cianfarani F, Failla C, Zambruno G, J Dermatol Sci 2006 41 11 19 10.1016/j.jdermsci.2005.08. 008 16216466 (Pubitemid 43075428)
50. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice. Graiani G, Emmanueli C, Desortes E, Van Linthout S, Pinna A, Fiqueroa C, Manni L, Madeddu P, Diabetologica 2004 47 1047 1054 (Pubitemid 38918164)
51. Nerve growth factor induces angiogenic activity in a mouse model of hind limb ischaemia. Turrini P, Gaetano C, Antonelli A, Capogrossi M, Aloe L, Neurosci Lett 2002 323 109 112 10.1016/S0304-3940(02)00090-3 11950505 (Pubitemid 34310252)
52. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Davidson B, Reich R, Lazarovici P, Nesland J, Skrede M, Risberg B, Trope C, Florenes V, Clin Cancer Res 2003 9 2248 2259 12796393 (Pubitemid 36687650)
53. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbaucer L, Zielke A, Exp Clin Endocrinol Diabetes 2002 110 386 392 10.1055/s-2002-36424 12518248 (Pubitemid 36041889)
54. Increased growth factor mRNA stability may underlie elevated nerve growth factor secretion from hypertensive vascular smooth muscle cells. Sherer T, Tuttle J, Brain Res Mol 1998 62 167 174 10.1016/S0169-328X(98)00247-2 (Pubitemid 29010384)
55. Nerve growth factor and brain derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion. Hiltunen J, Laurikainen A, Vakeva A, Meri S, Saarma M, J Pathol 2001 194 247 253 10.1002/path.878 11400155 (Pubitemid 32519975)
56. Expression of nerve growth factor and TrkA after transient focal cerebral ischaemia in rats. Lee T, Kato H, Chen S, Kogure K, Itoyana Y, Stroke 1998 29 1687 1696 10.1161/01.STR.29.8.1687 9707213
57. Expression of von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: A potential method for objective assessment of tumor angiogenesis. Zanetta L, Marcusi S, Vasile J, Dobryansky M, Cohen H, Eng K, Shamamiam P, Mignatti P, Int J Cancer 2000 85 281 288 10629090 (Pubitemid 30023080)
58. Active hair growth (anagen) is associated with angiogenesis. Mecklenberg L, Tobin D, Muller-Rover S, Handjiski B, Wendt G, Peters E, Pohl S, Moll I, Paus R, J Invest Dermatol 2000 114 909 916 10.1046/j.1523-1747.2000.00954.x 10771470 (Pubitemid 30252710)
59. Melanoma: Tumor angiogenesis and human neoplasia. Hubler W, Wolf J, Cancer 1976 38 187 192 10.1002/1097-0142(197607)38:1<187::AID- CNCR2820380129>3.0.CO;2-D 947514
60. Vascular proliferation and angiogenic factors in psoriasis. Creamer J, Barker J, Clin Exp Dermatol 1995 20 6 9 10.1111/j.1365-2230.1995.tb01274.x 7545558
61. Lymphatic endothelium and Kaposis sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Jussila L, Valtola R, Partanen T, Cancer Res 1998 58 1599 1604 9563467 (Pubitemid 28215077)
62. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Henno A, Blacher S, Lambert C, Colige A, Seidel L, Noel A, Lapiere C, de la Brassinne M, Nusgens B, Br J Dermatol 1998 160 581 590
63. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: An approach of vascular development chronology in psoriasis. Henno A, Blacher S, Lambert C, Deroanne C, Noel A, Lapiere C, Brassinne M, Nusgens B, Colige A, J Dermatol Sci 2010 57 162 169 10.1016/j.jdermsci.2009.12. 006 20071151
64. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth facto are elevated in psoriasis. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE, Br J Dermatol 1999 141 1054 1060 10.1046/j.1365-2133. 1999.03205.x 10606852 (Pubitemid 30046195)
65. Circulating vascular permeability factor/vascular endothelial growth factor in erythroderma. Creamer D, Allen M, Groves R, Barket J, Lancet 1996 348 1101 10.1016/S0140-6736(05)64447-9 8874475 (Pubitemid 26343614)
66. Psoriatic keratinocytes express high levels of nerve growth factor. Raychaudhuri S, Jiang W, Farber E, Acta Derm Venereol 1998 78 84 86 10.1080/000155598433368 9534881 (Pubitemid 28153332)
67. Nerve growth factor is increased in psoriatic skin. Fantini F, Magnoni C, Brauci-Laudeis L, Pincelli C, J Invest Dermatol 1995 105 854 855 10.1111/1523-1747.ep12326689 7490482 (Pubitemid 26005611)
68. Nerve growth factor as an angiogenic factor. Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D, Microvas Res 2008 75 135 141 10.1016/j.mvr.2007.07.004 (Pubitemid 351249859)
69. Cross-talk between the cardiovascular and nervous systems: Neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF) - Implications in drug development. Lazarovici P, Marcinikiewicz C, Lelkes P, Curr Pharm Des 2006 14 2609 2622